Product Details:
Packaging Size | BOX |
Brand | MOLSUN |
Manufacturer | SUNRISE |
Composition | Molnupiravir 400mg Tablets |
Strength | 400mg |
Form | Capsules |
Also gives | PCD Pharma |
Country of Origin | Made in India |
Product Specification
Packaging Size |
40 Capsule |
Composition |
Molnupiravir |
Treatment |
Covid 19 |
Strength |
200 Mg |
Prescription/Non prescription |
Prescription |
Brand |
Movfor |
Shelf life |
2 Years |
Country of Origin |
Made in India |
Product DescriptionMolnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further.